1 / 6

GLP-1 Receptor Agonist Market

GLP-1 Receptor Agonist Market Size Worth USD 257.12 Billion by 2034 | CAGR: 17.14%

sam310
Download Presentation

GLP-1 Receptor Agonist Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GLP-1 Receptor Agonist Market GLP-1 Receptor Agonist Market Size Worth USD 257.12 Billion by 2034 | CAGR: 17.14% GLP-1 Receptor Agonist Market Size, Share, & Industry Analysis Report: By Route of Administration (Parenteral and Oral), By Product, By Application, By Distribution Channel, and By Region – Market Forecast, 2025–2034

  2. GLP-1 Receptor Agonist Market • The global GLP-1 receptor agonist market size was valued at USD 53.02 billion in 2024, growing at a CAGR of 17.14% during 2025– 2034. Request To Sample : https://www.polarismarketresearch.com/industry-analysis/glp-1- receptor-agonist-market/request-for-sample

  3. GLP-1 Receptor Agonist Market • Key Market Players : • Amgen Inc. • AstraZeneca • Boehringer Ingelheim International GmbH • Genentech, Inc. • Hanmi Pharm.Co., Ltd. • Innovent • Lilly • Novo Nordisk A/S • Pfizer Inc. • Sanofi

  4. GLP-1 Receptor Agonist Market GLP-1 Receptor Agonist Market Report Highlights • In terms of product, the ozempic segment led the GLP-1 receptor agonist market in 2024, attributed to its proven clinical efficiency, strong brand awareness, and broad utilization in type 2 diabetes treatment protocols. • Based on application, the obesity segment is poised for expansion during the forecast period, fueled by increasing global obesity pharmacotherapies. • In 2024, the North America GLP-1 receptor agonist market accounted for the largest revenue share, owing to high metabolic disorder prevalence, early uptake of innovative therapies, and robust healthcare systems. • Asia Pacific is anticipated to exhibit the highest growth rate during the forecast period, propelled by surging diabetes and obesity incidence in key regional markets. rates and growing demand for advanced Buy Now :https://www.polarismarketresearch.com/buy/4736/0

  5. ????? ??: Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. ??????? ????: Polaris Market Research Phone: +1-929-297-9727 Email: sales@polarismarketresearch.com

More Related